These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18294242)

  • 1. Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread.
    Grude N; Strand L; Mykland H; Nowrouzian FL; Nyhus J; Jenkins A; Kristiansen BE
    Clin Microbiol Infect; 2008 May; 14(5):498-500. PubMed ID: 18294242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of fluoroquinolone-resistant clonal group A: clonal analysis of Norwegian and Russian E. coli isolates.
    Strand L; Jenkins A; Grude N; Allum AG; Mykland HC; Nowrouzian FL; Kristiansen BE
    APMIS; 2010 Aug; 118(8):571-7. PubMed ID: 20666738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
    Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
    Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP; Manges AR; Riley LW
    Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections.
    Shigemura K; Arakawa S; Miura T; Nakano Y; Tanaka K; Fujisawa M
    Jpn J Infect Dis; 2008 May; 61(3):226-8. PubMed ID: 18503177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan.
    Kawamura-Sato K; Yoshida R; Shibayama K; Ohta M
    Jpn J Infect Dis; 2010 Mar; 63(2):113-5. PubMed ID: 20332573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
    Killgore KM; March KL; Guglielmo BJ
    Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.
    Moreno E; Prats G; Sabaté M; Pérez T; Johnson JR; Andreu A
    J Antimicrob Chemother; 2006 Feb; 57(2):204-11. PubMed ID: 16390858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray.
    Yu X; Susa M; Weile J; Knabbe C; Schmid RD; Bachmann TT
    Int J Med Microbiol; 2007 Oct; 297(6):417-29. PubMed ID: 17482874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of genomic profiles of Escherichia coli isolates from urinary tract infections.
    Usein CR; Damian M; Tatu-Chiţoiu D; Căpuşă C; Făgăraş R; Mircescu G
    Roum Arch Microbiol Immunol; 2003; 62(3-4):137-54. PubMed ID: 16008140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli.
    France AM; Kugeler KM; Freeman A; Zalewski CA; Blahna M; Zhang L; Marrs CF; Foxman B
    Clin Infect Dis; 2005 Apr; 40(8):1101-7. PubMed ID: 15791508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli.
    Yamane T; Enokida H; Hayami H; Kawahara M; Nakagawa M
    Int J Urol; 2012 Apr; 19(4):360-8. PubMed ID: 22211478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel.
    Wolk M; Valinsky L; Sompolinsky D; Sechter I; Schmidt H; Tetry S; Agmon V
    FEMS Microbiol Lett; 2004 Oct; 239(2):249-54. PubMed ID: 15476973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli clonal group A among uropathogenic infections in Mexico City.
    Manjarrez-Hernandez A; Molina-López J; Gavilanes-Parra S; Hernandez-Castro R
    J Med Microbiol; 2016 Dec; 65(12):1438-1444. PubMed ID: 27902433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
    Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.
    Longhi C; Marazzato M; Conte MP; Iebba V; Schippa S; Seganti L; Comanducci A
    J Antibiot (Tokyo); 2009 Feb; 62(2):109-11. PubMed ID: 19198637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.